Home › Products › Oncology › Biomab Egfr 50mg Injection
Biomab Egfr 50mg Injection
Salt Composition: NIMOTUZUMAB
- Manufacturer: ERIS LIFESCIENCES LIMITED
- Pack Size: 4 VIAL(s) OF 10ML
- Dosage Form: INJECTION
- Strength: 50MG
- Prescription Required
- Cold Chain
- Prepaid Only. Non-Returnable.
- Storage: Biomab EGFR 50mg Injection should be stored in a refrigerator at a temperature between 2°C to 8°C (36°F to 46°F). Not need to be frozen, as this can damage its efficacy. Once a vial is opened, it should be used immediately. If the drug is not used immediately, it can be stored at room temperature for 4 hours. After 4 hours, any remaining drug should be discarded. Keep out of reach of children and pets.
₹39198.00₹55997.44
Inclusive of all taxes
Product Introduction
Biomab EGFR 50mg Injection contains the active ingredient Nimotuzumab, a monoclonal antibody used in cancer treatment. It is approved for the treatment of head and neck cancer and certain types of brain cancer. This medication is typically administered alongside other cancer treatments, such as chemotherapy and radiation therapy. The drug may improve overall survival and disease-free survival in some cancer patients. As with all cancer treatments, side effects can occur, including allergic reactions, skin rashes, and flu-like symptoms.
There are no absolute contraindications to Biomab EGFR 50mg Injection, though precautions and potential contraindications exist. Patients with a history of severe allergic reactions or hypersensitivity to Nimotuzumab or its components should not receive the medication. Additionally, patients with certain medical conditions, such as severe liver or kidney disease, may require close monitoring or dosage adjustments.
Uses
Head and neck cancer Certain types of brain cancer Esophageal cancer
How it works
The therapeutic effect of Biomab EGFR 50mg Injection is primarily focused on its ability to target and bind to the epidermal growth factor receptor (EGFR) found on many cancer cells. Doing so can block the growth and spread of cancer cells, ultimately leading to improved patient outcomes. One of the advantages is its targeted therapy approach, which allows it to target cancer cells while minimizing damage to healthy cells specifically. This can help to reduce side effects and improve the overall quality of life for cancer patients undergoing treatment.
How to Use
Biomab EGFR 50mg Injection is an injectable medication that a healthcare professional administers. It is typically given as an intravenous injection. The dose and frequency will depend on the type of cancer being treated, the patient's overall health, and other medications the patient may be taking. If you miss a dose, contact your healthcare provider as soon as possible. Your healthcare provider may recommend rescheduling your next dose or adjusting your dosing schedule. Do not double the dose to make a missed dose.
Side Effects
Like all medications, Biomab EGFR 50mg Injection can cause side effects, although not everyone who takes it will experience them. Serious: Allergic reactions Difficulty breathing Swelling of the face or throat, or hives Infusion reactions (fever, chills, or low blood pressure) Chest pain Irregular heartbeat Lung problems (cough or shortness of breath) Liver problems (jaundice or abdominal pain) Common: Skin rash Diarrhea Nausea and vomiting Fatigue Headache Fever Pain at the injection site
Expert Tips
It is important to carefully read the medication label before taking Biomab EGFR 50mg Injection. Follow the instructions provided by your healthcare provider and the label, such as how much to take and how often. Your healthcare provider can provide more information on the risks and benefits of it and can help you determine if it is the right treatment option for you. It is important to report any side effects you may experience during treatment to your healthcare provider. Pregnancy and breastfeeding are not recommended while taking this medication. Before starting it or any other medication, inform your healthcare provider of any allergies or medications you are taking. This can help prevent any potential interactions or adverse effects.
References
- KD Tripathi, Essentials of Medical Pharmacology, 7th edition, Jaypee Brothers Medical Publishers (P) Ltd.; 2013, 893-894.
- Goodman & Gilman's The Pharmacological Basis of Therapeutics (Brunton, L.L., Chabner, B.A., and Knollmann, B.C., eds.). Biomab EGFR 50mg Injection. 13th edition, 1461-1463.
- Bespons Pvt Ltd, U.S. Food and Drug Administration., Highlights of prescribing information - Biomab EGFR 50mg Injection, [Last updated: March 2020],[10 April 2023], Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/761040s000lbl.pdf
- S.H. Ibbotson, R.S. Dawe, Skin Disease, Davidsonâs Principles & Practice of Medicine, 22nd Edition, 2014, 1249-1305
Safety Advice
Pregnancy: unsafe Biomab EGFR 50mg Injection is not safe for an unborn baby. Therefore, it is not recommended for pregnant women.
Lungs: unsafe If you have a pre-existing lung condition or disease, such as chronic obstructive pulmonary disease (COPD) or asthma, inform your healthcare provider before starting treatment. In some cases, it may cause lung toxicity, leading to symptoms such as cough, shortness of breath, wheezing, or chest pain.
Breastfeeding: Consult your doctor There is limited information on whether Biomab EGFR 50mg Injection passes into breast milk, so it is important to talk to your healthcare provider before breastfeeding.
Disclaimer
The information provided on this page is intended for general informational purposes only and should not be considered as medical advice. Always consult a qualified healthcare professional before starting, stopping, or changing any medication. Self-medication can be harmful. Med For Rare does not endorse self-diagnosis or self-treatment.